Giselle Moreira Mirna, Guimarães Oliveira Anna Gabriella, Ul Haq Ihtisham, Pinheiro de Oliveira Tatiana Flávia, Alonazi Wadi B, Fonseca Júnior Antônio Augusto, Nobre Junior Vandack Alencar, Santos Simone Gonçalves Dos
Departament of Microbiology, Institute of Biological Sciences, Federal University of Minas Gerais, Av. Pres. Antônio Carlos 6627, Pampulha, Belo Horizonte 31270-901, Minas Gerais, Brazil.
Department of Physical Chemistry and Technology of Polymers, Silesian University of Technology, M. Strzody 9, 44-100 Gliwice, Poland.
Antibiotics (Basel). 2024 Sep 13;13(9):878. doi: 10.3390/antibiotics13090878.
Advanced diagnostic technologies have made accurate and precise diagnosis of pathogens easy. Herein, we present a new diagnostic method, droplet digital PCR (ddPCR), to detect and quantify in mini bronchoalveolar lavage (mini-BAL) samples. ventilator-associated pneumonia (VAP), a severe healthcare infection affecting patients' lungs. VAP carries a high risk of morbidity and mortality, making its timely diagnosis crucial for prompt and effective management. Methodology. The assay performance was evaluated by comparing colonization data, quantitative culture results, and different generations of PCR (traditional PCR and Real-Time PCR-qPCR Taqman and SYBR Green). The ddPCR and qPCR Taqman prove to be more sensitive than other molecular techniques. Reasonable analytical specificity was obtained with ddPCR, qPCR TaqMan, and conventional PCR. However, qPCR SYBR Green technology presented a low specificity, making the results questionable in clinical samples. DdPCR detected/quantified in more clinical samples than other methods (38.64% of the total samples). This emerging ddPCR technology offers promising advantages such as detection by more patients and direct quantification of pathogens without calibration curves.
先进的诊断技术使对病原体进行准确精确的诊断变得容易。在此,我们提出一种新的诊断方法——微滴式数字PCR(ddPCR),用于检测和定量小型支气管肺泡灌洗(mini-BAL)样本中的病原体。呼吸机相关性肺炎(VAP)是一种影响患者肺部的严重医疗感染。VAP具有很高的发病和死亡风险,因此其及时诊断对于迅速有效的治疗至关重要。方法。通过比较定植数据、定量培养结果以及不同代的PCR(传统PCR和实时PCR——qPCR Taqman和SYBR Green)来评估检测性能。ddPCR和qPCR Taqman被证明比其他分子技术更敏感。ddPCR、qPCR TaqMan和传统PCR具有合理的分析特异性。然而,qPCR SYBR Green技术特异性较低,使得临床样本中的结果存在疑问。与其他方法相比,ddPCR在更多临床样本中检测到/定量了病原体(占总样本的38.64%)。这种新兴的ddPCR技术具有诸多有前景的优势,例如能检测更多患者,且无需校准曲线即可直接定量病原体。